Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy.

Pharmaceutics · 2021 · PMC8541575 · PMID 34684020

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

In summary, we successfully prepared an injectable, biocompatible, biodegradable, targeted, safe, effective, and controlled-release nanoscale preparation, which may be significant in promoting more nanoscale preparations for hydrophobic drugs to be applied in clinical practice.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.